Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia
EP Europace · 16.02.2023 · 25 (2) · 619-626
DOI: 10.1093/europace/euac177 ↗Kurz gefasst
Fachartikel in der Zeitschrift EP Europace, online erschienen am 12.11.2022. Verfasst von Puck J Peltenburg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Cardiolgy, Heart Center, Amsterdam UMC, University of Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Ventricular Premature Complexes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ZonMW Priority Medicines for Rare Diseases, Mayo Clinic, Netherlands CardioVascular Research Initiative.
Abstract (Originalsprache)
Aims
In catecholaminergic polymorphic ventricular tachycardia (CPVT), the exercise-stress test (EST) is the cornerstone for the diagnosis, risk stratification, and assessment of therapeutic efficacy, but its repeatability is unknown. We aimed to test the repeatability of ventricular arrhythmia characteristics on the EST in patients with CPVT. Methods and results EST-pairs (ESTs performed within 18 months between 2005 and 2021, on the same protocol, and without or on the exact same treatment) of patients with RYR2-mediated CPVT from two specialized centres were included. The primary endpoint was the repeatability of the maximum ventricular arrhythmia score [VAS: 0 for the absence of premature ventricular contractions (PVCs); 1 for isolated PVCs; 2 for bigeminal PVCs; 3 for couplets; and 4 for non-sustained ventricular tachycardia]. Secondary outcomes were the repeatability of the heart rate at the first PVC and the ΔVAS (the absolute difference in VAS between the EST-pairs). A total of 104 patients with 349 EST-pairs were included. The median duration between ESTs was 343 (interquartile range, 189–378) days. Sixty (17.2%) EST-pairs were off therapy. The repeatability of the VAS was moderate {Krippendorf α, 0.56 [95% confidence interval (CI), 0.48–0.64]}, and the repeatability of the heart rate at the first PVC was substantial [intra-class correlation coefficient, 0.78 (95% CI, 0.71–0.84)]. The use of medication was associated with a higher odds for a ΔVAS > 1 (odds ratio = 3.52; 95% CI, 2.46–4.57; P = 0.020).
Conclusion
The repeatability of ventricular arrhythmia characteristics was moderate to substantial. This underlines the need for multiple ESTs in CPVT patients and CPVT suspicious patients and it provides the framework for assessing the therapeutic efficacy of novel CPVT therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Cardiolgy, Heart Center, Amsterdam UMC, University of Amsterdam, the Netherlands.
- Department of Pediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 Amsterdam, AZ, The Netherlands.
- Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics, Division of Heart Rhythm Services and Pediatric Cardiology, Windland Smith Rice Sudden D…
- Department of Pediatric Cardiology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Albinusdreef 2, 2333 Leiden, ZA, The Netherlands.
ORCID-Profile: Puck J Peltenburg, J Martijn Bos, Krystien V V Lieve, Michael Tanck, Sally-Ann B Clur, Nico A Blom, Michael J Ackerman, Arthur A M Wilde, Christian van der Werf
Förderung
- ZonMW Priority Medicines for Rare Diseases
- Mayo Clinic
- Netherlands CardioVascular Research Initiative
- Dutch Heart Foundation
- Dutch Federation of University Medical Centers
- Netherlands Organisation for Health Research and Development
- Royal Netherlands Academy of Sciences
- AEPC
Zitieren
APA
Peltenburg, P. J., Pultoo, S. N. J., Tobert, K. E., Bos, J. M., Lieve, K. V. V., Tanck, M., Clur, S. B., Blom, N. A., Ackerman, M. J., Wilde, A. A. M., & van der Werf, C. (2023). Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia. EP Europace, 25(2), 619-626. https://doi.org/10.1093/europace/euac177
Vancouver
Peltenburg PJ, Pultoo SNJ, Tobert KE, Bos JM, Lieve KVV, Tanck M, et al. Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia. EP Europace. 2023;25(2):619-626. doi:10.1093/europace/euac177
BibTeX
@article{Peltenburg2023,
author = {Peltenburg, Puck J and Pultoo, Sanjeev N J and Tobert, Kathryn E and Bos, J Martijn and Lieve, Krystien V V and Tanck, Michael and Clur, Sally-Ann B and Blom, Nico A and Ackerman, Michael J and Wilde, Arthur A M and van der Werf, Christian},
title = {Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia},
journal = {EP Europace},
year = {2023},
volume = {25},
number = {2},
pages = {619--626},
doi = {10.1093/europace/euac177}
}
EUVIMED